Bruker Corporation, a Massachusetts-based scientific instruments manufacturer, reported in its quarterly SEC filing, that on April 25, 2019, the SEC informed the company that it had concluded its investigation into payments for non-employee travel expenses, financial reporting, and certain accounting practices, and that it would not pursue an enforcement action against the company. Additionally, the company reported that its board of directors concluded a previously-disclosed internal investigation into potential FCPA questions involving the practices of business partners and former employees in China. The filing did not disclose the conclusions of that internal investigation.
May 8, 2019
Bruker Corporation reports conclusion of SEC investigation
Related by Topic
New Post
The EU’s Omnibus Package introduces substantial changes to EU sustainability legislation including the CSRD and CSDDD
May 6, 2025
Insight
New Post
Indonesia-based PT Telkom discloses two U.S. investigations, including an FCPA inquiry
May 1, 2025
News Alert
New Post
Merit Medical Systems discloses SEC inquiry into its China-based subsidiary
May 1, 2025
News Alert